The aim of this study was to determine whether the two T2D-associated SNPs were associated with alternative splicing or differences in gene expression levels, using peripheral blood mononuclear cells (PBMCs) as the potential target of TCF7L2 expression in T2D pathogenesis. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.